For a patient receiving trastuzumab deruxtecan (Enhertu) who develops grade 1 pneumonitis, how should the dose be reduced and what are the recommended steps for management and re‑initiation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: February 7, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

How to manage pneumonitis related to trastuzumab deruxtecan (Trastuzumab deruxtecan, Anti-HER2 therapy)?

How to taper corticosteroids (CS) in a patient with pneumonitis due to trastuzumab deruxtecan (trastuzumab emtansine) after initial 14-day treatment with 1mg/kg?

How to taper corticosteroids in pneumonitis secondary to trastuzumab deruxtecan?

What are the pulmonary complications associated with Trastuzumab (trastuzumab) therapy?

What is the management of interstitial lung disease (ILD) secondary to trastuzumab deruxtecan (trastuzumab and deruxtecan)?

In an asymptomatic patient with heart failure with reduced ejection fraction who is already on a stable ACE inhibitor, should he be switched to an angiotensin receptor‑neprilysin inhibitor (sacubitril/valsartan)?

In a patient with bilateral renal artery stenosis of approximately 50% and a subintimal thrombus in one renal artery, with a creatinine clearance of about 110 mL/min, what is the optimal management strategy?

What is the recommended furosemide dose and titration schedule for an elderly patient with heart‑failure‑related fluid congestion?

What effect does polymyalgia rheumatica have on anemia in an elderly patient?

In an elderly patient with focal seizures caused by neurocysticercosis, what antiepileptic and antiparasitic drugs, dosing, and safety considerations are recommended?

What ear‑wax softening drops (e.g., carbamide peroxide) and administration protocol are recommended for cerumen removal, and what are the contraindications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.